IL17A and psoriasis: It is generally accepted that excessive activation of innate and adaptive immune response is critical for psoriasis pathogenesis via production of interleukin‐17 (IL‐17), interferon‐γ (IFN‐γ) and tumour necrosis factor‐α (TNF‐α).1, 2